Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | December 27, 2022 01:31pm

Gainers

  • Quotient (NASDAQ:QTNT) shares increased by 129.0% to $0.44 during Tuesday's regular session. As of 12:30 EST, Quotient's stock is trading at a volume of 20.9 million, which is 8106.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.5 million.
  • 180 Life Sciences (NASDAQ:ATNF) stock rose 67.58% to $2.08. Trading volume for this security as of 12:30 EST is 43.9 million, which is 7441.9% of its average full-day volume over the last 100 days. The company's market cap stands at $4.2 million.
  • HTG Molecular Diagnostics (NASDAQ:HTGM) shares moved upwards by 50.81% to $4.68. As of 12:30 EST, this security is trading at a volume of 22.0 million shares, making up 4714.2% of its average full-day volume over the last 100 days. The company's market cap stands at $4.7 million.
  • First Wave BioPharma (NASDAQ:FWBI) shares moved upwards by 19.86% to $0.55. As of 12:30 EST, this security is trading at a volume of 270.2K shares, making up 37.4% of its average full-day volume over the last 100 days. The company's market cap stands at $3.2 million.
  • Virax Biolabs Group (NASDAQ:VRAX) stock increased by 19.28% to $0.68. Trading volume for this security as of 12:30 EST is 669.4K, which is 55.4% of its average full-day volume over the last 100 days. The company's market cap stands at $8.7 million.
  • KalVista Pharma (NASDAQ:KALV) stock increased by 17.02% to $5.98. The current volume of 1.0 million shares is 245.4% of KalVista Pharma's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $147.2 million.

Losers

  • Acer Therapeutics (NASDAQ:ACER) stock declined by 35.5% to $2.4 during Tuesday's regular session. Acer Therapeutics's stock is trading at a volume of 2.1 million shares as of 12:30 EST. This is 608.2% of its average full-day volume over the last 100 days. The company's market cap stands at $46.8 million.
  • Intelligent Bio Solutions (NASDAQ:INBS) stock decreased by 20.03% to $0.23. Trading volume for Intelligent Bio Solutions's stock is 126.9K as of 12:30 EST. This is 309.4% of its average full-day volume over the last 100 days. The company's market cap stands at $4.1 million.
  • Cosmos Health (NASDAQ:COSM) stock decreased by 19.0% to $5.18. As of 12:30 EST, this security is trading at a volume of 2.1 million shares, making up 39.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $40.2 million.
  • Scopus BioPharma (NASDAQ:SCPS) stock declined by 17.83% to $0.11. Scopus BioPharma's stock is trading at a volume of 70.9K shares as of 12:30 EST. This is 7.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.2 million.
  • Yield10 Bioscience (NASDAQ:YTEN) shares decreased by 17.5% to $1.65. The company's market cap stands at $8.1 million.
  • Soligenix (NASDAQ:SNGX) stock declined by 16.84% to $0.54. Soligenix's stock is trading at a volume of 134.5K shares as of 12:30 EST. This is 169.3% of its average full-day volume over the last 100 days. The company's market cap stands at $23.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACER ATNF COSM FWBI HTGM INBS KALV QTNT SCPS SNGX VRAX YTEN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist